• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 68Ga-PSMA PET/CT 偶然检测肾细胞癌转移的甲状腺癌以评估前列腺癌复发。

Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence.

机构信息

From the *Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg; and †Department of Clinical Medicine, Aalborg University, Aalborg; ‡Department of Urology, Regional Hospital West Jutland, Holstebro, Denmark; and §Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.

出版信息

Clin Nucl Med. 2017 Mar;42(3):221-222. doi: 10.1097/RLU.0000000000001522.

DOI:10.1097/RLU.0000000000001522
PMID:28033223
Abstract

Ga-PSMA PET/CT is increasingly used to assess prostate cancer. Avid Ga-PSMA uptake by thyroid cancer and renal cell carcinoma (RCC) has been reported in few cases. A 75-year-old man who received a diagnosis of RCC in 2006 and prostate cancer in 2009 presented with elevated prostate-specific antigen levels (0.7 ng/mL) following prostatectomy. Ga-PSMA PET/CT showed avid Ga-PSMA uptake in 1 pelvic and 1 retroperitoneal lymph node and focal Ga-PSMA accumulation in the thyroid. Excised retroperitoneal lymph node and thyroid tissues showed metastases from RCC, whereas the pelvic lymph node exhibited metastasis from prostate cancer.

摘要

镓-PSMA PET/CT 正越来越多地用于评估前列腺癌。在少数病例中,曾报道过甲状腺癌和肾细胞癌(RCC)摄取镓-PSMA 明显增加的情况。一位 75 岁男性,2006 年被诊断为 RCC,2009 年被诊断为前列腺癌,前列腺切除术后前列腺特异性抗原水平升高(0.7ng/mL)。镓-PSMA PET/CT 显示 1 个骨盆和 1 个腹膜后淋巴结摄取 Ga-PSMA 明显增加,甲状腺局灶性 Ga-PSMA 聚集。切除的腹膜后淋巴结和甲状腺组织显示 RCC 转移,而骨盆淋巴结显示前列腺癌转移。

相似文献

1
Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence.使用 68Ga-PSMA PET/CT 偶然检测肾细胞癌转移的甲状腺癌以评估前列腺癌复发。
Clin Nucl Med. 2017 Mar;42(3):221-222. doi: 10.1097/RLU.0000000000001522.
2
Multiphasic Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients.多期 Ga-PSMA PET/CT 在 PSA 水平<1ng/mL 的前列腺癌患者早期复发检测中的应用:一项对 135 例患者的前瞻性研究。
J Nucl Med. 2020 Oct;61(10):1484-1490. doi: 10.2967/jnumed.119.238071. Epub 2020 Feb 14.
3
The use of Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma.镓-PET/CT PSMA 在原发性和疑似复发性肾细胞癌分期中的应用。
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2280-2288. doi: 10.1007/s00259-019-04432-2. Epub 2019 Jul 23.
4
Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma.18F-FDG PET/CT 和 68Ga-前列腺特异性膜抗原 PET/CT 摄取的互补模式:转移性透明细胞肾细胞癌病例报告。
Clin Nucl Med. 2016 Dec;41(12):e517-e519. doi: 10.1097/RLU.0000000000001394.
5
Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen ( Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection.根治性前列腺切除术后加病理阳性淋巴结清扫术,前列腺特异性膜抗原(Ga-PSMA)正电子发射/计算机断层扫描后前列腺癌复发的分布。
BJU Int. 2020 Jun;125(6):876-883. doi: 10.1111/bju.15052. Epub 2020 Apr 23.
6
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.68Ga-PSMA HBED-CC PET 对生化复发前列腺癌患者淋巴结转移评估的价值:与挽救性淋巴结切除术后组织病理学的比较。
J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3.
8
Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [Ga]PSMA I&T and comparison with published data of [Ga]PSMA HBED-CC.使用[镓]PSMA I&T检测前列腺癌生化复发患者中PET/CT的检出率,并与[镓]PSMA HBED-CC的已发表数据进行比较。
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):670-677. doi: 10.1007/s00259-016-3572-5. Epub 2016 Nov 28.
9
Clinical performance of Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy.Ga-PSMA-11 PET/MRI 用于检测根治性前列腺切除术后复发性前列腺癌的临床性能。
Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):20-30. doi: 10.1007/s00259-017-3850-x. Epub 2017 Oct 14.
10
Comparison of  Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer.比较 Ga-PSMA 配体 PET/CT 与传统的横断面成像在前列腺癌转移性淋巴结转移的转移灶定向放疗中的靶区勾画。
Strahlenther Onkol. 2019 May;195(5):420-429. doi: 10.1007/s00066-018-1417-9. Epub 2019 Jan 4.

引用本文的文献

1
Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule.使用前列腺特异性膜抗原(PSMA)正电子发射断层扫描/计算机断层扫描(PET/CT)检测转移至既往存在的甲状腺结节的前列腺癌。
NPJ Precis Oncol. 2024 Jun 15;8(1):132. doi: 10.1038/s41698-024-00619-5.
2
Utility of PSMA PET/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis.PSMA PET/CT 在肾细胞癌分期和再分期中的应用:系统评价和荟萃分析。
J Nucl Med. 2024 Jul 1;65(7):1007-1012. doi: 10.2967/jnumed.124.267417.
3
The clinical signification and application value of [Ga]Ga-PSMA imaging in thyroid malignancy.
^68^Ga-PSMA 成像在甲状腺恶性肿瘤中的临床意义及应用价值。
Endocrine. 2024 May;84(2):598-606. doi: 10.1007/s12020-023-03599-x. Epub 2023 Nov 21.
4
Prostate-specific membrane antigen expression predicts recurrence of papillary thyroid carcinoma after total thyroidectomy.前列腺特异性膜抗原表达预测甲状腺全切除术后甲状腺乳头状癌的复发。
BMC Cancer. 2022 Dec 7;22(1):1278. doi: 10.1186/s12885-022-10375-z.
5
PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports.PSMA 放射性配体疗法治疗除前列腺癌以外的实体瘤:背景、机遇、挑战和初步临床报告。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4350-4368. doi: 10.1007/s00259-021-05433-w. Epub 2021 Jun 12.
6
Lesion-to-background ratio threshold value of SUVmax of simultaneous [Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer.前列腺癌患者同时进行[镓]镓-PSMA-11 PET/MRI成像时SUVmax的病变与背景比值阈值
Insights Imaging. 2020 Dec 17;11(1):137. doi: 10.1186/s13244-020-00926-y.
7
[Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.[镓]镓-PSMA-11在前列腺癌中的应用:综述
Am J Nucl Med Mol Imaging. 2020 Dec 15;10(6):349-374. eCollection 2020.
8
Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?肾细胞癌:肿瘤专家问,PSMA PET/CT 能回答吗?
Curr Urol Rep. 2019 Oct 11;20(11):68. doi: 10.1007/s11934-019-0938-9.
9
A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).前列腺特异性膜抗原(PSMA)正电子发射断层扫描(PET)在肾细胞癌(RCC)中的应用综述。
Mol Imaging Biol. 2019 Oct;21(5):799-807. doi: 10.1007/s11307-018-01307-0.
10
Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients.镓-PSMA PET/CT 在根治性治疗后复发前列腺癌患者中的应用:314 例患者的前瞻性结果。
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2035-2044. doi: 10.1007/s00259-018-4067-3. Epub 2018 Jun 19.